A Personalized and Effective Approach to Metabolic Syndrome Prevention

1024 379 Techna

As rates of Metabolic Syndrome (MetS) and corresponding chronic disease – including obesity, type 2 diabetes, heart disease and stroke – continue to rise throughout North America, the need for innovation on preventative measures is critical. In the US, 79% of the population has one or more symptoms of MetS and 20% of all healthcare costs – ~$600B – are driven by conditions associated with MetS. Jeff is going to talk about a novel personalized health approach to MetS prevention gaining traction with major US insurers and employers to lower healthcare costs.


JeffRubyJeff Ruby is the Founder & CEO of Newtopia, a leading personalized health company. Jeff is a health innovator with an extensive track record in preventive health. Prior to founding Newtopia, Jeff was Co-Founder and Chief Operating Officer of Cleveland Clinic Canada, a collaboration between the Cleveland Clinic Foundation and Canyon Ranch, and Canada’s leading destination for preventive health and lifestyle management. Before that, he served as Co-Founder and Chief Operating Officer of Life Screening Centres Inc. alongside a diversified group of international health product and service companies as part of The Copeland Group of Companies. Prior to the Copeland Group, Jeff was a Co-Founder and Director of Operations of Genetic Diagnostics Inc., an early stage biotechnology company commercializing a new genetic diagnostic testing platform. Jeff has a joint Juris Doctorate and Masters of Business Administration (JD/MBA) from Osgoode Hall and the Schulich School of Business in Toronto and a Bachelor of Arts degree from Western University. Jeff is a global thought leader and expert on integrative, personalized and highly engaging strategies to deliver affordable and sustainable health outcomes and behaviour change.

Click here to view the Event Flyer in PDF format.